Ginsenoside Ro has been shown to enhance 5-fluorouracil sensitivity in esophageal cancer by disrupting autophagic flux through the ESR2-NCF1-ROS pathway, leading to CHEK1-mediated DNA damage activation (43). Here, ESR2 is linked to esophageal cancer.